Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05815342 · ClinicalTrials.gov registry record · NA
OP5-005 Using Omnipod 5 in Adults With Type 2
A NA study, sponsored by Insulet Corporation.
- Completed
- Registry status
- NA
- Development phase
- 343
- Enrollment target
NCT05815342 is a NA study that has completed, run by Insulet Corporation. The registered enrollment target is 343 participants.
The verdict
NCT05815342, a NA study, has completed, sponsored by Insulet Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 343 participants
- Enrollment target
Study Summary
This is a single arm, multi-center, prospective study that will evaluate the safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes requiring insulin therapy.
Interventions
- DEVICE Omnipod 5 Automated Glucose Control System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2023-04-11 |
| Est. Completion | 2024-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05815342
The ClinicalTrials.gov registry entry for NCT05815342 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 343 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Insulet Corporation, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omnipod 5 Automated Glucose Control System is the first listed.
NCT05815342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05815342 about?
NCT05815342 is a clinical study titled "OP5-005 Using Omnipod 5 in Adults With Type 2". This is a single arm, multi-center, prospective study that will evaluate the safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes requiring insulin therapy.
What is the current status of trial NCT05815342?
This trial is currently completed. It is a NA study. The enrollment target is 343 participants. The study started on 2023-04-11. Estimated completion is 2024-03-01.
What interventions are being tested in trial NCT05815342?
The interventions under investigation include: Omnipod 5 Automated Glucose Control System (DEVICE).
Who is sponsoring clinical trial NCT05815342?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.